Integral Diagnostics Ltd
Integral Diagnostics Limited is an Australia-based provider of medical imaging services across Australia and New Zealand.
The business
Integral Diagnostics Limited is an Australia-based provider of medical imaging services across Australia and New Zealand. The principal activity of the Company is the provision of diagnostic imaging services. The Company operates over145 clinics in Australia and New Zealand through various brands, such as Lake Imaging, Capital Radiology, Future Medical Imaging Group (FMIG), The X-ray Group, Direct Radiology, Imaging @ Olympic Park, Lime Avenue Radiology, Imaging Queensland, South Coast Radiology, Radiology Tasmania, Apex Radiology, Capital Radiology, Fowler Simmons Radiology, Astra Radiology, Trinity MRI, SRG Radiology and Horizon Radiology, among others. Lake Imaging offers radiology services to patients throughout Geelong, Central and Western Victoria. Capital Radiology offers a full range of diagnostic imaging services including low-dose digital x-ray, ultrasound, low-dose CT, echocardiography, 3T MRI, mammography, bone densitometry (DEXA), and interventional radiology services.
Small Caps Research
No research on Integral Diagnostics Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise IDX based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news

Integral Diagnostics Lifts FY26 Earnings as Capitol Synergies Beat Expectations
Integral Diagnostics FY26 revenue up 25.6% to A$788.7m; NPAT up 50% to A$47.4m as Capitol synergies beat; final dividend 6.0c; margins lift.

Integral Diagnostics to expand NZ footprint with acquisition of Ascot Radiology
Australian medical imaging services company Integral Diagnostics (ASX: IDX) plans to extend its New Zealand footprint by year end with the $47.7 million acquisition of specialist imaging technology firm Ascot Radiology. The purchase consideration will comprise $38.2 million in cash and $9.5 million in new ordinary Integral shares to be issued at $3.48 per share […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.